This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Europe: Oligonucleotide and Peptide Therapeutics
11-13 November 2025
Congress Center BaselBasel, Switzerland

Niall McLoughlin, PhD
Senior Scientist, Process Chemistry & Catalysis at F. Hoffmann-La Roche AG
Speaker

Profile

Niall McLoughlin is a Senior Scientist specializing in late-stage peptide process development at Roche. He holds an undergraduate degree in Medicinal Chemistry from Trinity College Dublin and a master's in Drug Discovery & Development from Imperial College London. In 2020, Niall completed his PhD at VU Amsterdam under the supervision of Prof. Tom Grossmann, focusing on the design and synthesis of peptide-based RNA-targeting ligands. After transitioning to industry, he spent two years as a process development chemist at the CDMO Polypeptide, overseeing peptide process development from milligram to kilogram scale across various clinical stages. Before joining Roche in 2024, Niall served as a quality assessor at the European Directorate for the Quality of Medicines.

Agenda Sessions

  • Assessing the Risks and Stability of Nitroso-Drug Substance-Related Impurities in Synthetic Peptide API's

    14:00